Not recruiting
Glycogen storage disease type II
Not recruitingStudy on Long-term Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Adults with Late-onset Pompe Disease
InvestigationalNo placebo
Study on Long-term Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Adults with Late-onset Pompe Disease
InvestigationalNo placebo
- Disease:Glycogen storage disease type II
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
